AI assistant
CADOUX LIMITED — Director's Dealing 2007
Sep 12, 2007
64620_rns_2007-09-12_6b74eb26-ef4d-4726-be90-fad108b063c2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
| Name | of entitySolbec Pharmaceuticals Ltd |
|---|---|
| ABN | 85 061 289 218 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Grant Karl Maynard BENNETT |
|---|---|
| Date of last notice | 13thSeptember 2007 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Direct or indirect interest | Direct and Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. | AMB Holdings Pty Ltd(Director shareholder) |
| Date of change | 6 September 2007 |
| No. of securities held prior to change | 4,844,286 Ordinary Shares (direct)255,413 Ordinary Shares (indirect) |
| Class | Ordinary Shares and Options |
| Number acquired | 10,000,000 Options expiring 30/06/2010exercisable at 0.7cents |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Nil |
| No. of securities held after change | 4,844,286Ordinary Shares (direct)255,413 Ordinary Shares (indirect)10,000,000 Options expiring 30/06/2010exercisable at 0.7cents (indirect) |
| Nature of changeExample: on-market trade, off-market trade, exercise of options,issueofsecuritiesunderdividendreinvestmentplan,participation in buy-back | 10,000,000 options received in consideration forfinancing facility |
- See chapter 19 for defined terms.
30/9/2001
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
- See chapter 19 for defined terms.
30/9/2001
Appendix 3Y Page 2